Ora, Inc.
2K posts
Ora, Inc.
@oraclinical
Ora is the world's leading full-service ophthalmic drug and device development firm with offices in the United States, United Kingdom, Australia, and Asia.
Andover, MA, USA Katılım Şubat 2010
487 Takip Edilen796 Takipçiler
August is Children's Eye Health & Safety Month. This month aims to raise awareness about the importance of taking care of children's eyes. #pediatrics #childrenseyehealth #pediatricvision
English
#DryEyeJuly is ending, but practicing healthy habits to protect your eyes should never stop! Until next year....#OraCares #EyeHealthAwareness #dryeyedisease
English
Ora, Inc. retweetledi
In this #CME activity, experts describe how retinal specialists can implement the use of gene therapy in practice once it becomes more widely available. Learn & earn your #FreeCME here >> ow.ly/ly5850LEKYk
English
Starting the week on the final day of the month. Can you believe it's already August?! #MotivationMonday
English
The weekend is almost here! Don't forget to "Beware the Glare"! Make sure you protect your eyes from the sun, especially if you suffer from #DryEye! #DryEyeJuly #DryEyeRelief #dryeyedisease #oracares
English
English
Andrew D. Huberman, Ph.D.@hubermanlab
A major takeaway from my recent conversation with Chair of Ophthalmology @StanfordMed: kids and adults should get outside 2 hours a day. Why? It can offset myopia (near-sightedness) & development of myopia. How? Still unclear but it’s likely sunlight and far-viewing combined. On your screen and/or inside too much = degraded vision. Get outside folks. And kids especially.
English
English
Ora, Inc. retweetledi
NEWS: Our research exploring an investigational treatment in #HidradenitisSuppurativa advances into Phase 3. Read the latest update: bit.ly/3DoZGE8
English
Ora, Inc. retweetledi
4D Molecular Therapeutics has completed enrollment of the Phase 2 Dose Expansion stage of the PRISM clinical trial. This trial is for patients with wet age-related macular degeneration (wet AMD).
Learn more: ow.ly/5FYA50Ph9Fx
English
Ora, Inc. retweetledi
Ora, Inc. retweetledi
Intelligent Retinal Imaging Systems has partnered with AEYE Health to allow IRIS to license AEYE Diagnostic Screening (AEYE-DS) from AEYE Health. This system is an FDA-cleared AI technology that seamlessly integrates with the IRIS Solution.
Read more: ow.ly/jsq350PbPaP
English
It's a brand-new week and an opportunity to do something great! Make it count! #oracares #oraeye #MotivationMonday
English
Heading outdoors this weekend? If you suffer from Drye Eye Disease and have light sensitivity, don't forget to wear your sunglasses! #dryeyejuly #oraeye #oracares #visionhealth
English
Did you know that daily screen time has increased by almost 50 minutes per day since 2013 and that the average person spends 7 hours and 4 minutes looking at a screen each day? Give your eyes a break! Don't forget to blink! #dryeyejuly #dryeyes #oracares
English
Ora, Inc. retweetledi
Bayer has shared the 2-year (96 weeks) topline results of the PHOTON clinical trial, which investigates the company’s novel aflibercept 8 mg with dosing regimens of up to 24 weeks in diabetic macular edema (DME).
Read more: ow.ly/UKRw50P6a8L
English
English
Ora, Inc. retweetledi
. @PBA_savingsight Declares July as Dry Eye Awareness Month to Educate Public on Eye Disease that Affects more than 16 Million Americans buff.ly/3NWD2ch
English